Submitted by Anonymous (not verified) on 14 November 2025 - 10:33
Human medicines European public assessment report (EPAR): Juluca, dolutegravir,rilpivirine, Date of authorisation: 16/05/2018, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Juluca, dolutegravir,rilpivirine, Date of authorisation: 16/05/2018, Revision: 16, Status: Authorised